The data reflect the lasting effect of gunshot wounds on victims, with poor physical and psychosocial outcomes after 5 years, indicating that the burden of gun violence extends beyond mortality and economic cost.
Patients with treatment resistant depression (TRD), defined as at least 3 treatment trials within a single depressive episode, were matched with 5 controls with non-treatment–resistant depression.
The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline.
The CRAFFT screening tool has acceptable concurrent and predictive value for substance use and substance use disorders in youth who visit pediatric emergency departments, and has value in predicting substance use disorders at follow-up.
Early-onset psychiatric comorbidity was primarily associated with increased risk for natural death in adults with ADHD, while later-onset psychiatric comorbidity was more often associated with death due to such causes as suicide and unintentional injury.
The prevalence of cluster headache may be higher in individuals with a substance use disorder than in the general population.
Expanded Medicaid eligibility thresholds were associated with a reduction in substance use disorder-related deaths during the current US opioid epidemic.
Hearing loss is independently associated with substance use disorders among those aged 49 years and younger.
Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.
Physicians reported that a lack of training in brief intervention and reimbursement make providing screening and intervention more difficult when caring for youth with possible substance use disorders.